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A B S T R A C T
Milk-alkali syndrome is mainly caused by the ingestion of large amounts of calcium and absorbable
alkali. This syndrome can lead to metastatic calciﬁcation, renal failure and metabolic alkalosis secondary
to hypercalcemia. Hypercalcemia is rarely a cause of seizure activity. Very few case reports have been
published linking seizure to hypercalcemia, but only one recent case report about mesial temporal
sclerosis relates the seizure activity to Milk-alkali syndrome. This is another report regarding seizure
associated with excess calcium carbonate intake, but without any evidence of mesial temporal sclerosis.
The patient described in this article, suffered from status epilepticus most likely secondary to
hypercalcemia. Evaluations for malignancy, thyroid, and parathyroid dysfunctions were non conclusive,
therefore hypercalcemia in our patient was attributed to milk-alkali syndrome given the history of the
prolonged calcium carbonate intake.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Hypercalcemia may present with nausea, vomiting, constipa-
tion, lethargy, polyuria, polydipsia, nocturia and headache.
Neurological manifestations of hypercalcemia include altered
mental status, weakness, muscle and joint aches, depression and
in severe cases encephalopathy and coma.1 Seizures induced by
hypercalcemia are rare.2
The aim of this report is to show that hypercalcemia due to milk
alkali syndrome can induce status epilepticus in patients without
prior history of seizures. Our patient presented with status
epilepticus and was thought to be secondary to hypercalcemia.
On the basis of the laboratory ﬁndings and clinical picture, we
concluded that hypercalcemia secondary to milk alkali syndrome
can induce status epilepticus.
2. Case report
A 57-year-old man was brought to the emergency department
accompanied by his son because of altered mental status. History
was ﬁrst obtained from the son. The patient had no signiﬁcant past
medical history other than acid reﬂux disease. According to the
son, he noticed the patient agitated, confused, disoriented and he
then became unresponsive and aphasic by time he reached the* Corresponding author. Tel.: +1 212 844 6571.
E-mail address: rkashouty@chpnet.org (R. Kashouty).
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doi:10.1016/j.seizure.2011.03.011hospital. While in the emergency department, patient was
witnessed having continuous generalized tonic-clonic seizure
activity with urinary incontinence, and was effectively controlled
with benzodiazepine and phenytoin. Patient was intubated for
airway protection and transferred to neurosurgery intensive care
unit. Labs showed: WBC, 17.0 K/mcL (4.8–10.8 K/mcL); Hgb,
14.9 gm/dL (14.0–18.0 gm/dL); platelet, 274 K/mcL (150–400 K/
mc L); PT, 10.8 s (10.3–12.4 s); PTT, 28.8 s (24.7–35.1 s); glucose,
176 mg/dL (70–99 mg/dL); BUN, 28 mg/dL (6–20 mg/dL); creati-
nine, 4.1 mg/dL (0.6–1.2 mg/dL); sodium, 138 mEq/L (136–
145 mEq/L); potassium, 3.4 mEq/dL (3.5–5.1 mEq/dL); chloride,
93 mEq/dL (98–107 mEq/dL); calcium, 15.0 mg/dL (8.4–10.5 mg/
dL); venous serum pH, 7.502 (7.35–7.44); and bicarbonate,
29.9 mEq/L (22–28 mEq/L).
CT of the head originally done without contrast did not suggest
any infarction, hemorrhage or mass effect. No acute or chronic
processes were identiﬁed. No lumbar puncture was performed.
Follow-up CT scan with contrast and MRI were also unremarkable.
An EEG was performed after two days of his admission and showed
5–6 Hz theta activity with no potential asymmetries or epilepti-
form potentials identiﬁed. Photic stimulation did not evoke any
signiﬁcant abnormalities. A repeat EEG ﬁve days later showed
same results.
Once seizure activity was controlled with benzodiazepine and
phenytoin, patient was extubated, and was monitored closely for
any recurrence of seizure, which did not occur. Patient admitted on
taking 2–3 g of oral calcium carbonate tablets daily for his acid
reﬂux disease for the past ten years. He denied any history of headvier Ltd. All rights reserved.
Table 1
Calcium levels during hospitalization.
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R. Kashouty et al. / Seizure 20 (2011) 659–661660trauma, thyroid or parathyroid dysfunction, infection or any family
history of epilepsy. He did not recall exactly the events that
brought him to the hospital but he did remember that he was not
feeling well and felt nauseated and weak on the morning before his
admission. He denied having similar symptoms before.
Within few days, hypercalcemia resolved with proper hydra-
tion however the patient had transient hypocalcemia with a total
calcium level of 6.7 mg/dL. Acute renal failure gradually improved,
dialysis was not needed as calcium levels were steadily being
corrected (Table 1). Vitamin D-related hypercalcemia, uremic
encephalopathy and primary hyperparathyroidism were ruled out.
His intact PTH level was suppressed at 9.0 pg/mL (reference range,
15–65 pg/mL). CT of the thorax and abdomen/pelvis were
considered to help evaluate for possible malignancies, metastases,
sarcoidosis or Paget disease, however all results had proven to be
inconclusive of such ﬁndings.
Throughout the hospital course, patient did not have any
seizure activity, but his condition was complicated by bladder
outlet obstruction and underwent emergent cystoscopy. He later
developed right lower extremity edema secondary to an acute non-
occlusive right common femoral vein deep vein thrombosis and
IVC ﬁlter was placed successfully. Once the patient’s condition
stabilized, he was discharged to rehab on Keppra monotherapy and
lansoprazole for his reﬂux disease. He was counseled about his
health condition and was advised to avoid calcium carbonate
intake in excessive amounts. Patient remained seizure-free in the
following months.
3. Discussion
Milk-alkali syndrome is mainly caused by the ingestion of large
amounts of calcium and absorbable alkali, which can lead to
metastatic calciﬁcation, renal failure and metabolic alkalosis
secondary to hypercalcemia. Hypercalcemia is rarely a cause of
seizure activity. Very few case reports have been published linking
seizure to hypercalcemia, but only one recent case report relates
the seizure activity to milk-alkali syndrome in a patient who was
later found to have mesial temporal sclerosis.3 Other cases have
also been published relating seizures to hypercalcemia in a
pregnant woman with history of hyperparathyroidism4 and a
patient secondary to vitamin D toxicity2 but none were associated
with milk-alkali syndrome.
The patient in this report was found to have hypercalcemia and
renal failure with status epilepticus in the setting of excessive
chronic calcium intake. The patient denied any history of seizure,
head trauma or infection. He was evaluated for malignancy,
paraneoplastic syndrome, thyroid or parathyroid dysfunction, and
all results were inconclusive of such ﬁndings. CT of the head did notsuggest any infarction, hemorrhage or mass effect. No acute or
chronic processes were identiﬁed. Follow-up CT scan with contrast
and MRI of the brain were also unremarkable. The exogenous oral
calcium intake was thought to be the cause of the hypercalcemia.
Therefore, the ﬁndings of hypercalcemia, metabolic alkalosis and
kidney failure lead us to the diagnosis of milk-alkali syndrome in
our patient. Once hypercalcemia resolved and patient was seizure-
free for few months, we concluded that hypercalcemia secondary
to milk-alkali syndrome can induce status epilepticus. Few reports
discuss the etiology of hypercalcemia-induced seizure, which may
be secondary to hypercalcemia causing cerebral vasospasm5 or
associated with membrane instability.6
The history of milk-alkali syndrome dates back to 1910s where
Sippy reported a great success in treatment of peptic ulcer disease
in response to milk-alkali therapy consisting of milk and sodium
bicarbonate. The regimen was known as Sippy’s regimen and
quickly became the standard for ulcer treatment.7
Cope8 described multiple side effects associated with Sippy’s
regimen in 1936. Patients were found to have hypercalcemia, renal
impairment, hypermagnesemia, hyperphosphatemia which sub-
sequently resolved with discontinuation of milk alkali therapy. In
1949, Burnett et al.9 published a report of 6 male patients treated
with milk and absorbable alkali for peptic ulcer disease. Patients
had similar ﬁndings to Cope’s report.
Originally the incidence of milk-alkali syndrome among
hospitalized patients with peptic ulcer disease was approximately
1% described by Wenger et al.10 but decreased substantially after
the clinical introduction of nonabsorbable alkali and histamine-2
blockers.11 By 1970s and 1980s, milk-alkali syndrome was
responsible for less than 1–2% of all hospitalized patients with
hypercalcemia.12
However over the past few years, milk-alkali syndrome has had
a resurgence, as consumption of supplements containing calcium
has increased in patients with dyspepsia, in postmenopausal
women, patients receiving long-term corticosteroid therapy, and
patients with renal failure.13,14 Milk-alkali syndrome is no longer a
merely a historical curiosity or a rare condition; it is currently the
third most common cause of hypercalcemia and physicians should
suspect milk-alkali syndrome in patients hospitalized with
hypercalcemia.14,15
No clear etiology have been described between hypercalcemia
and seizure, however, Chen et al.5 had suggested that reversible
cerebral vasoconstriction may play a role in hypercalcemia-
induced seizures. More studies are needed to identify such
correlation. While this report does not prove an absolute link
between hypercalcemia and status epilepticus, there is a reason to
suspect that hypercalcemia secondary to milk-alkali syndrome can
induce status epilepticus. Given the increased incidence of milk-
alkali syndrome, it is reasonable to suspect an increased risk of
seizure activity in patients with excessive and prolonged calcium
supplementation. 2–3 g of calcium carbonate daily supplementa-
tion may be tolerated in many patients, but the prolonged use may
render the person susceptible to hypercalcemia. Since calcium
supplementation in the general population has become ‘‘trendy’’,
physicians should be aware about this possible complication.
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